Medical affairs, MSLs, and clinical communication
Navigating the complex landscape of FDA regulations can be daunting for biopharmaceutical
The Trump administration’s unprecedented decision to implement layoffs at the Department of
As the quest for longer, healthier lives intensifies, the biopharmaceutical industry is
On October 8, 2025, Vinay Prasad, the director of the FDA’s Center
In a significant move for Eli Lilly, Peter Marks has been appointed
The biopharma industry is on the cusp of a significant breakthrough with
